Updates are available Correction dated 2024-10-14
Click to view Correction: https://doi.org/10.1007/s00296-024-05692-4
-
Authors
Kadam, Esha https://orcid.org/0000-0002-8739-4502
Javaid, Mahnoor https://orcid.org/0000-0002-1501-1031
Sen, Parikshit https://orcid.org/0000-0002-1630-6026
Saha, Sreoshy https://orcid.org/0000-0001-6745-9770
Ziade, Nelly https://orcid.org/0000-0002-4479-7678
Day, Jessica https://orcid.org/0000-0001-8528-4361
Wincup, Chris https://orcid.org/0000-0002-8742-8311
Andreoli, Laura https://orcid.org/0000-0002-9107-3218
Parodis, Ioannis https://orcid.org/0000-0002-4875-5395
Tan, Ai Lyn https://orcid.org/0000-0002-9158-7243
Shinjo, Samuel Katsuyuki https://orcid.org/0000-0002-3682-4517
Dey, Dzifa https://orcid.org/0000-0002-3339-5112
Cavagna, Lorenzo https://orcid.org/0000-0003-3292-1528
Chatterjee, Tulika https://orcid.org/0000-0001-8844-851X
Knitza, Johannes https://orcid.org/0000-0001-9695-0657
Wang, Guochun https://orcid.org/0000-0002-4616-9376
Dalbeth, Nicola https://orcid.org/0000-0003-4632-4476
Velikova, Tsvetelina https://orcid.org/0000-0002-0593-1272
Battista, Simone https://orcid.org/0000-0002-7471-1951
Cheng, Karen https://orcid.org/0009-0004-3850-8480
Boyd, Peter https://orcid.org/0009-0009-4753-8717
Kobert, Linda https://orcid.org/0000-0002-3374-1003
Gracia-Ramos, Abraham Edgar https://orcid.org/0000-0003-1842-2554
Mittal, Srijan
Makol, Ashima https://orcid.org/0000-0002-8748-898X
Gutiérrez, Carlos Enrique Toro https://orcid.org/0000-0002-6084-7049
Uribe, Carlo V Caballero https://orcid.org/0000-0002-9845-8620
Kuwana, Masataka https://orcid.org/0000-0001-8352-6136
Burmester, Gerd-Rüdiger https://orcid.org/0000-0001-7518-1131
Guillemin, Francis https://orcid.org/0000-0002-9860-7024
Nikiphorou, Elena https://orcid.org/0000-0001-6847-3726
Chinoy, Hector https://orcid.org/0000-0001-6492-1288
Aggarwal, Vikas https://orcid.org/0000-0002-2089-027X
Gupta, Latika https://orcid.org/0000-0003-2753-2990
,
- License Information
-
More Information
Article History
Received: 13 November 2023
Accepted: 21 February 2024
First Online: 12 April 2024
Change Date: 14 October 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00296-024-05692-4
Declarations
:
: ALT has received honoraria for advisory boards and speaking for Abbvie, Gilead, Janssen, Lilly, Novartis, Pfizer, and UCB. EN has received speaker honoraria/participated in advisory boards for Celltrion, Pfizer, Sanofi, Gilead, Galapagos, AbbVie, and Lilly, and holds research grants from Pfizer and Lilly. HC has received consulting fees as a speaker for GSK, UCB; Advisory Board member for Astra Zeneca, Pfizer, Argenx, Galapagos; Data and Science Monitoring Board chair for Horizon Therapeutics. IP has received research funding and/or honoraria from Amgen, AstraZeneca, Aurinia Pharmaceuticals, Elli Lilly and Company, Gilead Sciences, GlaxoSmithKline, Janssen Pharmaceuticals, Novartis and F. Hoffmann-La Roche AG. JD has received research funding from CSL Limited. KC is the lead at the European Patient Advocacy Group (ePAG) and a patient with myositis. LK works at The Myositis Association which receives support from Octapharma, Mallinckrodt, Pfizer, argenx, Alexion, Janssen, Abcuro, Priovant, Horizon, and EMD Serono. MK has received speaker honoraria/participated in advisory boards for Asahi-Kasei, AstraZeneca, Boehringer-Ingelheim, Chugai, isai, GSK, Kissei, BML, Mochida, Nippon Shinyaku, Ono Pharmaceuticals, and Tanabe-Mitsubishi. ND has received consulting fees, speaker fees or grants from AstraZeneca, Novartis, Horizon, Selecta, Arthrosi, JW Pharmaceutical Corporation, PK Med, LG Chem, JPI, PTC Therapeutics, Protalix, Unlocked Labs, Hikma, Dexoligo Therapeutics. NZ has received speaker fees, advisory board fees, and research grants from Pfizer, Roche, Abbvie, Eli Lilly, NewBridge, Sanofi-Aventis, Boehringer Ingelheim, Janssen, and Pierre Fabre; none are related to this manuscript. TV has received speaker honoraria from Pfizer and AstraZeneca, non-related to the current manuscript. The rest of the authors have no conflict of interest relevant to this manuscript.
: The ethical approval has been obtained from the Institutional Ethics Committee at the SGPGIMS, Raebareli Road, Lucknow, India, postal code 226014.
